- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Theses and Dissertations /
- Development of liposomal bupivacaine using a transmembrane...
Open Collections
UBC Theses and Dissertations
UBC Theses and Dissertations
Development of liposomal bupivacaine using a transmembrane pH gradient Mowat, Jeffrey John
Abstract
There is a clear clinical requirement for longer acting local anaesthetics, particularly for the management of post-operative and chronic pain. In this regard, liposomes have been suggested to represent a potentially useful vehicle for sustained drug release following local administration. In this thesis, a transmembrane pH gradient was employed to efficiently encapsulate bupivacaine within large unilamellar vesicles. The rate and extent of bupivacaine uptake into large unilamellar vesicles exhibiting a pH gradient (interior acidic) were determined and compared to drug association with control liposomes that did not exhibit a proton gradient. Subsequent studies examined the kinetics of bupivacaine release from the liposome systems in vitro. Using the Guinea Pig cutaneous wheal model, the rate of clearance of the liposome carrier was monitored following intradermal administration employing a radiolabeled lipid marker and the duration of nerve blockade produced by free and liposomal bupivacaine compared. Intraperitoneal injections of bupivacaine encapsulated in pH gradient vesicles, control (no pH gradient vesicles) and free drug were completed in mice to determine the relative toxicities. While bupivacaine is rapidly and efficiently accumulated within liposomes exhibiting a pH gradient (interior acidic), little uptake was seen for control vesicles. Using an in vitro model of drug clearance, liposomally encapsulated bupivacaine was found to be released more slowly and over a longer period of time compared to either the free drug or bupivacaine associated with control (no pH gradient liposomes). In the Guinea Pig cutaneous wheal model, over 85% of the liposomal carrier was found to remain at the site of administration over two days and the sustained drug release afforded by liposomes exhibiting a pH gradient resulted in a threefold increase in the duration of nerve blockade compared to either the free drug or bupivacaine in the presence of control (no pH gradient) liposomes. In the toxicity study, bupivacaine encapsulated in pH gradient vesicles showed a greater than fourfold increase in safety compared to the use of the free drug and control (no pH gradient) vesicles. The present results clearly establish that large unilamellar vesicles exhibiting a pH gradient can efficiently encapsulate bupivacaine and subsequently provide a sustained release system that greatly increases the duration of neural blockade and, in addition, reduces the toxicity.
Item Metadata
Title |
Development of liposomal bupivacaine using a transmembrane pH gradient
|
Creator | |
Publisher |
University of British Columbia
|
Date Issued |
1994
|
Description |
There is a clear clinical requirement for longer acting local anaesthetics, particularly
for the management of post-operative and chronic pain. In this regard, liposomes have
been suggested to represent a potentially useful vehicle for sustained drug release
following local administration. In this thesis, a transmembrane pH gradient was employed
to efficiently encapsulate bupivacaine within large unilamellar vesicles.
The rate and extent of bupivacaine uptake into large unilamellar vesicles exhibiting
a pH gradient (interior acidic) were determined and compared to drug association with
control liposomes that did not exhibit a proton gradient. Subsequent studies examined the
kinetics of bupivacaine release from the liposome systems in vitro. Using the Guinea Pig
cutaneous wheal model, the rate of clearance of the liposome carrier was monitored
following intradermal administration employing a radiolabeled lipid marker and the
duration of nerve blockade produced by free and liposomal bupivacaine compared.
Intraperitoneal injections of bupivacaine encapsulated in pH gradient vesicles, control (no
pH gradient vesicles) and free drug were completed in mice to determine the relative
toxicities.
While bupivacaine is rapidly and efficiently accumulated within liposomes exhibiting
a pH gradient (interior acidic), little uptake was seen for control vesicles. Using an in
vitro model of drug clearance, liposomally encapsulated bupivacaine was found to be
released more slowly and over a longer period of time compared to either the free drug or
bupivacaine associated with control (no pH gradient liposomes). In the Guinea Pig
cutaneous wheal model, over 85% of the liposomal carrier was found to remain at the site of administration over two days and the sustained drug release afforded by liposomes
exhibiting a pH gradient resulted in a threefold increase in the duration of nerve blockade
compared to either the free drug or bupivacaine in the presence of control (no pH
gradient) liposomes. In the toxicity study, bupivacaine encapsulated in pH gradient
vesicles showed a greater than fourfold increase in safety compared to the use of the free
drug and control (no pH gradient) vesicles.
The present results clearly establish that large unilamellar vesicles exhibiting a pH
gradient can efficiently encapsulate bupivacaine and subsequently provide a sustained
release system that greatly increases the duration of neural blockade and, in addition,
reduces the toxicity.
|
Extent |
3423148 bytes
|
Genre | |
Type | |
File Format |
application/pdf
|
Language |
eng
|
Date Available |
2009-01-28
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
|
DOI |
10.14288/1.0098986
|
URI | |
Degree | |
Program | |
Affiliation | |
Degree Grantor |
University of British Columbia
|
Graduation Date |
1995-11
|
Campus | |
Scholarly Level |
Graduate
|
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.